The initial findings were a reduced hepatocarcinogenesis as well as slightly reduced tumor cell proliferation and moderately enhanced tumor cell death in the DEN/CCl4-treated Cxcl10−/− mice compared to identically treated WT mice. Here, CXCL10 is linked to neoplasm.